Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home. (Q50306838)

2 March 2018

http://europepmc.org/abstract/MED/26818535

title

Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home. (English)

1 reference

2 March 2018

http://europepmc.org/abstract/MED/26818535

author

Kyle Bradford Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Lisa M Ruiz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Mackenzie Damron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Dean Weedon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Paul S Carbone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Amanda V Bakian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Deborah A Bilder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

27 January 2016

1 reference

2 March 2018

http://europepmc.org/abstract/MED/26818535

published in

Journal of Autism and Developmental Disorders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1887-1894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

Medication patterns in patients with autism: temporal, regional, and demographic influences

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Body mass index in adults with intellectual disability: distribution, associations and service implications: a population-based prevalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Psychiatric comorbidity and medication use in adults with autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Use of psychotropic medication in children and adolescents with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Safety of antipsychotics in people with intellectual disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Weight gain and lipid-glucose profiles among patients taking antipsychotic medications: comparisons for prescriptions administered using algorithms versus usual care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Metabolic screening in children receiving antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Prevalence of psychotropic drug use in adults with intellectual disability: positive and negative findings from a large scale study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Building a person-centered medical home: lessons from a program for people with developmental disabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-016-2712-X

Predictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting

21 January 2018

1 reference

12 December 2020

Family history of type 2 diabetes in schizophrenic patients

1 reference

12 December 2020

The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review

1 reference

12 December 2020

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration

1 reference

12 December 2020

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

10.1007/S10803-016-2712-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26818535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference